APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Follicle Stimulating Hormones (FSH)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Veterinary Follicle Stimulating Hormones (FSH) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025184 pages

Choose your research edition.

Industry ResearchVeterinary Follicle Stimulating Hormones (FSH) Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Follicle Stimulating Hormones (FSH) Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Veterinary Follicle Stimulating Hormones (FSH) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Follicle Stimulating Hormones (FSH) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Follicle Stimulating Hormones (FSH) Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Veterinary Follicle Stimulating Hormones (FSH) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Veterinary Follicle Stimulating Hormones (FSH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Follicle Stimulating Hormones (FSH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Follicle Stimulating Hormones (FSH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Veterinary Follicle Stimulating Hormones (FSH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Veterinary Follicle Stimulating Hormones (FSH) include Vetoquinol, Trophogen, Inc, SUMU, Ningbo Second Hormone Factory, MSD, Laboratorios HIPRA, S.A. and Calier, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Veterinary Follicle Stimulating Hormones (FSH) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Follicle Stimulating Hormones (FSH) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Follicle Stimulating Hormones (FSH) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Follicle Stimulating Hormones (FSH) market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary Follicle Stimulating Hormones (FSH) Segment by Company

Vetoquinol

Trophogen, Inc

SUMU

Ningbo Second Hormone Factory

MSD

Laboratorios HIPRA, S.A.

Calier

Veterinary Follicle Stimulating Hormones (FSH) Segment by Type

Serum Gonadotrophin and Chorionic Gonadotrophin

Chorionic Gonadotrophin

Folltropin

Others

Veterinary Follicle Stimulating Hormones (FSH) Segment by Application

Horse

Bovine

Sheep

Others

Veterinary Follicle Stimulating Hormones (FSH) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Follicle Stimulating Hormones (FSH) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Follicle Stimulating Hormones (FSH) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Follicle Stimulating Hormones (FSH).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary Follicle Stimulating Hormones (FSH) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Veterinary Follicle Stimulating Hormones (FSH) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Veterinary Follicle Stimulating Hormones (FSH) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Veterinary Follicle Stimulating Hormones (FSH) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Veterinary Follicle Stimulating Hormones (FSH) Industry Trends Table 2. Veterinary Follicle Stimulating Hormones (FSH) Industry Drivers Table 3. Veterinary Follicle Stimulating Hormones (FSH) Industry Opportunities and Challenges Table 4. Veterinary Follicle Stimulating Hormones (FSH) Industry Restraints Table 5. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Manufacturers Table 9. Global Veterinary Follicle Stimulating Hormones (FSH) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Veterinary Follicle Stimulating Hormones (FSH) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Veterinary Follicle Stimulating Hormones (FSH) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Veterinary Follicle Stimulating Hormones (FSH) Manufacturers, Product Type & Application Table 13. Global Veterinary Follicle Stimulating Hormones (FSH) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary Follicle Stimulating Hormones (FSH) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Serum Gonadotrophin and Chorionic Gonadotrophin Table 17. Major Manufacturers of Chorionic Gonadotrophin Table 18. Major Manufacturers of Folltropin Table 19. Major Manufacturers of Others Table 20. Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Type (2021-2026) & (K Units) Table 22. Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Type (2027-2032) & (K Units) Table 23. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Type (2021-2026) Table 24. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Type (2027-2032) Table 25. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Type (2021-2026) & (K Units) Table 27. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Type (2027-2032) & (K Units) Table 28. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Type (2021-2026) Table 29. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Horse Table 31. Major Manufacturers of Bovine Table 32. Major Manufacturers of Sheep Table 33. Major Manufacturers of Others Table 34. Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Application (2021-2026) & (K Units) Table 36. Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Application (2027-2032) & (K Units) Table 37. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Application (2021-2026) Table 38. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Application (2027-2032) Table 39. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application (2021-2026) & (K Units) Table 41. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application (2027-2032) & (K Units) Table 42. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Application (2021-2026) Table 43. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Application (2027-2032) Table 44. Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region (2021-2026) & (K Units) Table 46. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Region (2021-2026) Table 47. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Veterinary Follicle Stimulating Hormones (FSH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2021-2026) & (K Units) Table 51. North America Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2027-2032) & (K Units) Table 52. Europe Veterinary Follicle Stimulating Hormones (FSH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2021-2026) & (K Units) Table 54. Europe Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Veterinary Follicle Stimulating Hormones (FSH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Veterinary Follicle Stimulating Hormones (FSH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2027-2032) & (K Units) Table 61. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Region (2021-2026) Table 65. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Region (2027-2032) Table 66. Vetoquinol Company Information Table 67. Vetoquinol Business Overview Table 68. Vetoquinol Veterinary Follicle Stimulating Hormones (FSH) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Vetoquinol Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio Table 70. Vetoquinol Recent Development Table 71. Trophogen, Inc Company Information Table 72. Trophogen, Inc Business Overview Table 73. Trophogen, Inc Veterinary Follicle Stimulating Hormones (FSH) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Trophogen, Inc Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio Table 75. Trophogen, Inc Recent Development Table 76. SUMU Company Information Table 77. SUMU Business Overview Table 78. SUMU Veterinary Follicle Stimulating Hormones (FSH) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. SUMU Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio Table 80. SUMU Recent Development Table 81. Ningbo Second Hormone Factory Company Information Table 82. Ningbo Second Hormone Factory Business Overview Table 83. Ningbo Second Hormone Factory Veterinary Follicle Stimulating Hormones (FSH) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Ningbo Second Hormone Factory Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio Table 85. Ningbo Second Hormone Factory Recent Development Table 86. MSD Company Information Table 87. MSD Business Overview Table 88. MSD Veterinary Follicle Stimulating Hormones (FSH) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. MSD Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio Table 90. MSD Recent Development Table 91. Laboratorios HIPRA, S.A. Company Information Table 92. Laboratorios HIPRA, S.A. Business Overview Table 93. Laboratorios HIPRA, S.A. Veterinary Follicle Stimulating Hormones (FSH) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Laboratorios HIPRA, S.A. Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio Table 95. Laboratorios HIPRA, S.A. Recent Development Table 96. Calier Company Information Table 97. Calier Business Overview Table 98. Calier Veterinary Follicle Stimulating Hormones (FSH) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Calier Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio Table 100. Calier Recent Development Table 101. Key Raw Materials Table 102. Raw Materials Key Suppliers Table 103. Veterinary Follicle Stimulating Hormones (FSH) Distributors List Table 104. Veterinary Follicle Stimulating Hormones (FSH) Customers List Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Veterinary Follicle Stimulating Hormones (FSH) Product Image Figure 2. Global Veterinary Follicle Stimulating Hormones (FSH) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Follicle Stimulating Hormones (FSH) Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Follicle Stimulating Hormones (FSH) Sales (2021-2032) & (K Units) Figure 5. Global Veterinary Follicle Stimulating Hormones (FSH) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Veterinary Follicle Stimulating Hormones (FSH) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Serum Gonadotrophin and Chorionic Gonadotrophin Image Figure 9. Chorionic Gonadotrophin Image Figure 10. Folltropin Image Figure 11. Others Image Figure 12. Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Type (2021-2032) Figure 15. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Type (2021-2032) Figure 18. Horse Image Figure 19. Bovine Image Figure 20. Sheep Image Figure 21. Others Image Figure 22. Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Application (2021-2032) Figure 25. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Application (2021-2032) Figure 28. North America Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Country (2021-2032) Figure 30. U.S. Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Country (2021-2032) Figure 35. Germany Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Country (2021-2032) Figure 42. China Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Country (2021-2032) Figure 50. Brazil Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Veterinary Follicle Stimulating Hormones (FSH) Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Veterinary Follicle Stimulating Hormones (FSH) Revenue (2021-2032) & (US$ Million) Figure 61. North America Veterinary Follicle Stimulating Hormones (FSH) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Veterinary Follicle Stimulating Hormones (FSH) Revenue (2021-2032) & (US$ Million) Figure 63. Europe Veterinary Follicle Stimulating Hormones (FSH) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Veterinary Follicle Stimulating Hormones (FSH) Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Veterinary Follicle Stimulating Hormones (FSH) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Veterinary Follicle Stimulating Hormones (FSH) Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Veterinary Follicle Stimulating Hormones (FSH) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Veterinary Follicle Stimulating Hormones (FSH) Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Veterinary Follicle Stimulating Hormones (FSH) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Serum Gonadotrophin and Chorionic Gonadotrophin
  • Chorionic Gonadotrophin
  • Folltropin
  • Others
Applications
  • Horse
  • Bovine
  • Sheep
  • Others
Companies covered
  • Vetoquinol
  • Trophogen, Inc
  • SUMU
  • Ningbo Second Hormone Factory
  • MSD
  • Laboratorios HIPRA, S.A.
  • Calier

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Veterinary Follicle Stimulating Hormones (FSH) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Veterinary Follicle Stimulating Hormones (FSH) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Veterinary Follicle Stimulating Hormones (FSH) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Veterinary Follicle Stimulating Hormones (FSH) Market Dynamics
  1. 2.1 Veterinary Follicle Stimulating Hormones (FSH) Industry Trends
  2. 2.2 Veterinary Follicle Stimulating Hormones (FSH) Industry Drivers
  3. 2.3 Veterinary Follicle Stimulating Hormones (FSH) Industry Opportunities and Challenges
  4. 2.4 Veterinary Follicle Stimulating Hormones (FSH) Industry Restraints
3 Veterinary Follicle Stimulating Hormones (FSH) Market by Manufacturers
  1. 3.1 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Veterinary Follicle Stimulating Hormones (FSH) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Veterinary Follicle Stimulating Hormones (FSH) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Veterinary Follicle Stimulating Hormones (FSH) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Veterinary Follicle Stimulating Hormones (FSH) Manufacturers, Product Type & Application
  7. 3.7 Global Veterinary Follicle Stimulating Hormones (FSH) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Veterinary Follicle Stimulating Hormones (FSH) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Veterinary Follicle Stimulating Hormones (FSH) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Veterinary Follicle Stimulating Hormones (FSH) Tier 1, Tier 2, and Tier 3
4 Veterinary Follicle Stimulating Hormones (FSH) Market by Type
  1. 4.1 Veterinary Follicle Stimulating Hormones (FSH) Type Introduction
  2. 4.1.1 Serum Gonadotrophin and Chorionic Gonadotrophin
  3. 4.1.2 Chorionic Gonadotrophin
  4. 4.1.3 Folltropin
  5. 4.1.4 Others
  6. 4.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Type
  7. 4.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Type (2021-2032)
  9. 4.2.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Type (2021-2032)
  10. 4.3 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Type
  11. 4.3.1 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Type (2021-2032)
  13. 4.3.3 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Type (2021-2032)
5 Veterinary Follicle Stimulating Hormones (FSH) Market by Application
  1. 5.1 Veterinary Follicle Stimulating Hormones (FSH) Application Introduction
  2. 5.1.1 Horse
  3. 5.1.2 Bovine
  4. 5.1.3 Sheep
  5. 5.1.4 Others
  6. 5.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Application
  7. 5.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Application (2021-2032)
  9. 5.2.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Application (2021-2032)
  10. 5.3 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application
  11. 5.3.1 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Application (2021-2032)
  13. 5.3.3 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Application (2021-2032)
6 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region
  1. 6.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region (2021-2026)
  4. 6.2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Veterinary Follicle Stimulating Hormones (FSH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Veterinary Follicle Stimulating Hormones (FSH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Veterinary Follicle Stimulating Hormones (FSH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Veterinary Follicle Stimulating Hormones (FSH) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region
  1. 7.1 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region
  2. 7.1.1 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region (2021-2026)
  4. 7.1.3 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Region (2027-2032)
  5. 7.1.4 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Veterinary Follicle Stimulating Hormones (FSH) Revenue (2021-2032)
  8. 7.2.2 North America Veterinary Follicle Stimulating Hormones (FSH) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Veterinary Follicle Stimulating Hormones (FSH) Revenue (2021-2032)
  11. 7.3.2 Europe Veterinary Follicle Stimulating Hormones (FSH) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Veterinary Follicle Stimulating Hormones (FSH) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Veterinary Follicle Stimulating Hormones (FSH) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Veterinary Follicle Stimulating Hormones (FSH) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Veterinary Follicle Stimulating Hormones (FSH) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Vetoquinol
  2. 8.1.1 Vetoquinol Company Information
  3. 8.1.2 Vetoquinol Business Overview
  4. 8.1.3 Vetoquinol Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Vetoquinol Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
  6. 8.1.5 Vetoquinol Recent Developments
  7. 8.2 Trophogen, Inc
  8. 8.2.1 Trophogen, Inc Company Information
  9. 8.2.2 Trophogen, Inc Business Overview
  10. 8.2.3 Trophogen, Inc Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Trophogen, Inc Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
  12. 8.2.5 Trophogen, Inc Recent Developments
  13. 8.3 SUMU
  14. 8.3.1 SUMU Company Information
  15. 8.3.2 SUMU Business Overview
  16. 8.3.3 SUMU Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 SUMU Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
  18. 8.3.5 SUMU Recent Developments
  19. 8.4 Ningbo Second Hormone Factory
  20. 8.4.1 Ningbo Second Hormone Factory Company Information
  21. 8.4.2 Ningbo Second Hormone Factory Business Overview
  22. 8.4.3 Ningbo Second Hormone Factory Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ningbo Second Hormone Factory Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
  24. 8.4.5 Ningbo Second Hormone Factory Recent Developments
  25. 8.5 MSD
  26. 8.5.1 MSD Company Information
  27. 8.5.2 MSD Business Overview
  28. 8.5.3 MSD Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MSD Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
  30. 8.5.5 MSD Recent Developments
  31. 8.6 Laboratorios HIPRA, S.A.
  32. 8.6.1 Laboratorios HIPRA, S.A. Company Information
  33. 8.6.2 Laboratorios HIPRA, S.A. Business Overview
  34. 8.6.3 Laboratorios HIPRA, S.A. Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Laboratorios HIPRA, S.A. Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
  36. 8.6.5 Laboratorios HIPRA, S.A. Recent Developments
  37. 8.7 Calier
  38. 8.7.1 Calier Company Information
  39. 8.7.2 Calier Business Overview
  40. 8.7.3 Calier Veterinary Follicle Stimulating Hormones (FSH) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Calier Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
  42. 8.7.5 Calier Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary Follicle Stimulating Hormones (FSH) Value Chain Analysis
  2. 9.1.1 Veterinary Follicle Stimulating Hormones (FSH) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary Follicle Stimulating Hormones (FSH) Production Mode & Process
  6. 9.2 Veterinary Follicle Stimulating Hormones (FSH) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary Follicle Stimulating Hormones (FSH) Distributors
  9. 9.2.3 Veterinary Follicle Stimulating Hormones (FSH) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst